Arthur Louie

Title: Arthur Louie: Innovator in Therapeutic Applications of Keratinocyte Growth Factor-2

Introduction

Arthur Louie is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of medicine through his innovative research and patents. His work primarily focuses on the therapeutic uses of keratinocyte growth factor-2 (KGF-2), which has implications for various medical treatments.

Latest Patents

Arthur Louie holds a patent for the therapeutic uses of keratinocyte growth factor-2. The present invention relates to the administration of KGF-2 to stimulate the proliferation of platelets and to increase levels of fibrinogen, albumin, globulin, and total serum protein. Furthermore, this invention addresses the administration of KGF-2 to protect or treat the bladder and prostate. Additionally, it involves stimulating the growth of nasal, oral, and esophageal mucosa, lacrimal glands, salivary glands, and Goblet cells.

Career Highlights

Arthur Louie is associated with Human Genome Sciences, Inc., where he has contributed to groundbreaking research and development in the field of biotechnology. His work has been instrumental in advancing therapeutic applications that can significantly improve patient outcomes.

Collaborations

Some of his notable coworkers include Pablo Jimenez and Donna Mendrick. Their collaborative efforts have further enhanced the research and development initiatives at Human Genome Sciences, Inc.

Conclusion

Arthur Louie's innovative work in the therapeutic applications of keratinocyte growth factor-2 showcases his dedication to advancing medical science. His contributions have the potential to make a lasting impact on various treatments and patient care.